388 related articles for article (PubMed ID: 26697917)
1. Proteogenomics for understanding oncology: recent advances and future prospects.
Subbannayya Y; Pinto SM; Gowda H; Prasad TS
Expert Rev Proteomics; 2016; 13(3):297-308. PubMed ID: 26697917
[TBL] [Abstract][Full Text] [Related]
2. Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification.
Fu S; Liu X; Luo M; Xie K; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2017 Apr; 14(4):351-362. PubMed ID: 28276747
[TBL] [Abstract][Full Text] [Related]
3. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
4. Proteogenomics approaches for studying cancer biology and their potential in the identification of acute myeloid leukemia biomarkers.
Hernandez-Valladares M; Vaudel M; Selheim F; Berven F; Bruserud Ø
Expert Rev Proteomics; 2017 Aug; 14(8):649-663. PubMed ID: 28693350
[TBL] [Abstract][Full Text] [Related]
5. Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction.
Dimitrakopoulos L; Prassas I; Diamandis EP; Charames GS
Crit Rev Clin Lab Sci; 2017 Sep; 54(6):414-432. PubMed ID: 29025326
[TBL] [Abstract][Full Text] [Related]
6. Proteogenomic Methods to Improve Genome Annotation.
Datta KK; Madugundu AK; Gowda H
Methods Mol Biol; 2016; 1410():77-89. PubMed ID: 26867739
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis and translational perspective of hepatocellular carcinoma: Identification of diagnostic protein biomarkers by an onco-proteogenomics approach.
Chiou SH; Lee KT
Kaohsiung J Med Sci; 2016 Nov; 32(11):535-544. PubMed ID: 27847095
[TBL] [Abstract][Full Text] [Related]
8. Proteogenomics: From next-generation sequencing (NGS) and mass spectrometry-based proteomics to precision medicine.
Ang MY; Low TY; Lee PY; Wan Mohamad Nazarie WF; Guryev V; Jamal R
Clin Chim Acta; 2019 Nov; 498():38-46. PubMed ID: 31421119
[TBL] [Abstract][Full Text] [Related]
9. Cancer proteogenomics: current impact and future prospects.
Mani DR; Krug K; Zhang B; Satpathy S; Clauser KR; Ding L; Ellis M; Gillette MA; Carr SA
Nat Rev Cancer; 2022 May; 22(5):298-313. PubMed ID: 35236940
[TBL] [Abstract][Full Text] [Related]
10. Clinical potential of mass spectrometry-based proteogenomics.
Zhang B; Whiteaker JR; Hoofnagle AN; Baird GS; Rodland KD; Paulovich AG
Nat Rev Clin Oncol; 2019 Apr; 16(4):256-268. PubMed ID: 30487530
[TBL] [Abstract][Full Text] [Related]
11. Proteogenomics.
Renuse S; Chaerkady R; Pandey A
Proteomics; 2011 Feb; 11(4):620-30. PubMed ID: 21246734
[TBL] [Abstract][Full Text] [Related]
12. The Proteogenomic Landscape of Curable Prostate Cancer.
Sinha A; Huang V; Livingstone J; Wang J; Fox NS; Kurganovs N; Ignatchenko V; Fritsch K; Donmez N; Heisler LE; Shiah YJ; Yao CQ; Alfaro JA; Volik S; Lapuk A; Fraser M; Kron K; Murison A; Lupien M; Sahinalp C; Collins CC; Tetu B; Masoomian M; Berman DM; van der Kwast T; Bristow RG; Kislinger T; Boutros PC
Cancer Cell; 2019 Mar; 35(3):414-427.e6. PubMed ID: 30889379
[TBL] [Abstract][Full Text] [Related]
13. Onco-proteogenomics: cancer proteomics joins forces with genomics.
Alfaro JA; Sinha A; Kislinger T; Boutros PC
Nat Methods; 2014 Nov; 11(11):1107-13. PubMed ID: 25357240
[TBL] [Abstract][Full Text] [Related]
14. Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify.
Komor MA; Pham TV; Hiemstra AC; Piersma SR; Bolijn AS; Schelfhorst T; Delis-van Diemen PM; Tijssen M; Sebra RP; Ashby M; Meijer GA; Jimenez CR; Fijneman RJA
Mol Cell Proteomics; 2017 Oct; 16(10):1850-1863. PubMed ID: 28747380
[TBL] [Abstract][Full Text] [Related]
15. Proteomic Approaches for Biomarker Panels in Cancer.
Tanase C; Albulescu R; Neagu M
J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
[TBL] [Abstract][Full Text] [Related]
16. Proteogenomic Analysis of Single Amino Acid Polymorphisms in Cancer Research.
Garin-Muga A; Corrales FJ; Segura V
Adv Exp Med Biol; 2016; 926():93-113. PubMed ID: 27686808
[TBL] [Abstract][Full Text] [Related]
17. Novel RNA-Affinity Proteogenomics Dissects Tumor Heterogeneity for Revealing Personalized Markers in Precision Prognosis of Cancer.
Wang L; Wrobel JA; Xie L; Li D; Zurlo G; Shen H; Yang P; Wang Z; Peng Y; Gunawardena HP; Zhang Q; Chen X
Cell Chem Biol; 2018 May; 25(5):619-633.e5. PubMed ID: 29503206
[TBL] [Abstract][Full Text] [Related]
18. Proteogenomics: Recycling Public Data to Improve Genome Annotations.
McAfee A; Foster LJ
Methods Enzymol; 2017; 585():217-243. PubMed ID: 28109431
[TBL] [Abstract][Full Text] [Related]
19. Combination of Proteogenomics with Peptide
Blank-Landeshammer B; Teichert I; Märker R; Nowrousian M; Kück U; Sickmann A
mBio; 2019 Oct; 10(5):. PubMed ID: 31615963
[TBL] [Abstract][Full Text] [Related]
20. Peptimapper: proteogenomics workflow for the expert annotation of eukaryotic genomes.
Guillot L; Delage L; Viari A; Vandenbrouck Y; Com E; Ritter A; Lavigne R; Marie D; Peterlongo P; Potin P; Pineau C
BMC Genomics; 2019 Jan; 20(1):56. PubMed ID: 30654742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
